Harrington Elizabeth O, Brunelle Jodi L, Shannon Christopher J, Kim Eric S, Mennella Kirstin, Rounds Sharon
Providence VA Medical Center, Department of Medicine, Brown Medical School, Providence, RI 02908, USA.
Am J Respir Cell Mol Biol. 2003 May;28(5):626-36. doi: 10.1165/rcmb.2002-0085OC.
Endothelial barrier dysfunction is involved in a variety of diseased states. We investigated the role of protein kinase C (PKC) in monolayer permeability using endothelial cells (EC) overexpressing PKC alpha (PKC alpha EC), PKC delta (PKC delta EC) or vector (vector control EC) cDNAs. Thrombin induced permeability changes in all EC, and induced significantly elevated rates of monolayer permeability in PKC alpha EC. Conversely, the basal level of permeability was significantly blunted in PKC delta EC, resulting in diminished thrombin-induced changes in permeability. PKC inhibitors, Gö6976 and rottlerin, reversed the effects of PKC alpha and PKC delta overexpression on permeability, respectively. Immunoblot analyses demonstrated significantly less beta-catenin associated with the cytoskeletal subcellular fraction in thrombin-treated PKC alpha EC, an effect blocked by pretreatment with Gö6976. PKC delta EC contained significantly greater numbers of focal contacts per cell. Thrombin enhanced RhoA GTPase activity in all EC; with a 3-fold greater level of activity in PKC delta EC. Rottlerin significantly blunted RhoA GTPase activity in all EC. Overexpression of RhoA dominant-negative cDNA diminished the size and number of focal contacts in EC, and significantly enhanced the basal rate of PKC delta EC monolayer permeability. These findings demonstrate that monolayer permeability changes are differentially regulated by PKC isoenzymes, suggesting that PKC alpha promotes endothelial barrier dysfunction and PKC delta enhances basal endothelial barrier function.
内皮屏障功能障碍涉及多种疾病状态。我们使用过表达蛋白激酶Cα(PKCα EC)、蛋白激酶Cδ(PKCδ EC)或载体(载体对照EC)cDNA的内皮细胞(EC),研究了蛋白激酶C(PKC)在单层通透性中的作用。凝血酶诱导所有EC的通透性变化,并在PKCα EC中诱导单层通透性显著升高。相反,PKCδ EC中的基础通透性水平显著降低,导致凝血酶诱导的通透性变化减弱。PKC抑制剂Gö6976和rottlerin分别逆转了PKCα和PKCδ过表达对通透性的影响。免疫印迹分析表明,在凝血酶处理的PKCα EC中,与细胞骨架亚细胞组分相关的β-连环蛋白显著减少,Gö6976预处理可阻断该效应。PKCδ EC每个细胞含有显著更多的粘着斑。凝血酶增强了所有EC中的RhoA GTP酶活性;在PKCδ EC中的活性水平高3倍。Rottlerin显著减弱了所有EC中的RhoA GTP酶活性。RhoA显性负性cDNA的过表达减少了EC中粘着斑的大小和数量,并显著提高了PKCδ EC单层通透性的基础速率。这些发现表明,单层通透性变化受PKC同工酶的差异调节,提示PKCα促进内皮屏障功能障碍,而PKCδ增强基础内皮屏障功能。